Geron Stock Buy Hold or Sell Recommendation

GERN Stock  USD 4.12  0.05  1.20%   
Given the investment horizon of 90 days and your way above-average risk tolerance, our recommendation regarding Geron is 'Hold'. The recommendation algorithm takes into account all of Geron's available fundamental, technical, and predictive indicators you will find on this site.
  
Check out Geron Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.
In addition, we conduct extensive research on individual companies such as Geron and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Execute Geron Buy or Sell Advice

The Geron recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Geron. Macroaxis does not own or have any residual interests in Geron or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Geron's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell GeronBuy Geron
Hold

Market Performance

Very WeakDetails

Volatility

Moderately volatileDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Almost neglects market trendsDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Geron has a Risk Adjusted Performance of (0.02), Jensen Alpha of (0.24), Total Risk Alpha of (0.59) and Treynor Ratio of (0.1)
We provide advice to complement the regular expert consensus on Geron. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Geron is not overpriced, please check out all Geron fundamentals, including its gross profit, short ratio, current asset, as well as the relationship between the total debt and beta . Given that Geron has a price to earning of (12.48) X, we strongly advise you to confirm Geron market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Geron Trading Alerts and Improvement Suggestions

Geron generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 237 K. Net Loss for the year was (184.13 M) with loss before overhead, payroll, taxes, and interest of (93.67 M).
Geron currently holds about 219.29 M in cash with (167.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
Over 85.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Geron Corp. Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts

Geron Returns Distribution Density

The distribution of Geron's historical returns is an attempt to chart the uncertainty of Geron's future price movements. The chart of the probability distribution of Geron daily returns describes the distribution of returns around its average expected value. We use Geron price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Geron returns is essential to provide solid investment advice for Geron.
Mean Return
-0.1
Value At Risk
-4.13
Potential Upside
4.17
Standard Deviation
2.90
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Geron historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Geron Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument, such as Geron, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Geron back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
Shares
Fmr Inc2024-09-30
15 M
Geode Capital Management, Llc2024-09-30
13.1 M
Wellington Management Company Llp2024-09-30
12.7 M
Jefferies Financial Group Inc2024-09-30
9.7 M
Deep Track Capital, Lp2024-09-30
7.6 M
Eventide Asset Management, Llc2024-09-30
7.1 M
Woodline Partners Lp2024-09-30
M
T. Rowe Price Associates, Inc.2024-09-30
M
Boxer Capital Llc2024-09-30
M
Blackrock Inc2024-06-30
46.6 M
Rtw Investments, Llc2024-09-30
44.1 M
Note, although Geron's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Geron Cash Flow Accounts

201920202021202220232024 (projected)
Change In Cash3.1M(3.6M)24.9M22.0M13.9M14.6M
Free Cash Flow(44.2M)(67.1M)(95.8M)(127.8M)(168.6M)(160.1M)
Depreciation776K935K783K868K1.0M1.4M
Other Non Cash Items68K264K984K626K(10.1M)(9.6M)
Capital Expenditures413K401K207K431K830K689.7K
Net Income(68.5M)(75.6M)(116.1M)(141.9M)(184.1M)(174.9M)
End Period Cash Flow13.9M10.3M35.2M57.2M71.1M40.4M
Investments27.8M(105.3M)70.6M62.5M(180.3M)(171.3M)
Change To Netincome6.4M6.7M6.9M8.3M9.5M7.1M

Geron Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Geron or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Geron's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Geron stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
-0.24
β
Beta against Dow Jones1.08
σ
Overall volatility
2.74
Ir
Information ratio -0.08

Geron Volatility Alert

Geron exhibits very low volatility with skewness of -0.25 and kurtosis of 1.06. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Geron's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Geron's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Geron Fundamentals Vs Peers

Comparing Geron's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Geron's direct or indirect competition across all of the common fundamentals between Geron and the related equities. This way, we can detect undervalued stocks with similar characteristics as Geron or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Geron's fundamental indicators could also be used in its relative valuation, which is a method of valuing Geron by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Geron to competition
FundamentalsGeronPeer Average
Return On Equity-0.69-0.31
Return On Asset-0.3-0.14
Operating Margin(1.00) %(5.51) %
Current Valuation2.24 B16.62 B
Shares Outstanding604.5 M571.82 M
Shares Owned By Insiders0.08 %10.09 %
Shares Owned By Institutions85.36 %39.21 %
Number Of Shares Shorted70.13 M4.71 M
Price To Earning(12.48) X28.72 X
Price To Book8.52 X9.51 X
Price To Sales85.51 X11.42 X
Revenue237 K9.43 B
Gross Profit(93.67 M)27.38 B
EBITDA(174.78 M)3.9 B
Net Income(184.13 M)570.98 M
Cash And Equivalents219.29 M2.7 B
Cash Per Share0.58 X5.01 X
Total Debt85.9 M5.32 B
Debt To Equity0.39 %48.70 %
Current Ratio4.85 X2.16 X
Book Value Per Share0.48 X1.93 K
Cash Flow From Operations(167.74 M)971.22 M
Short Ratio7.39 X4.00 X
Earnings Per Share(0.32) X3.12 X
Price To Earnings To Growth(2.38) X4.89 X
Target Price7.45
Number Of Employees14118.84 K
Beta0.52-0.15
Market Capitalization2.52 B19.03 B
Total Asset394.08 M29.47 B
Retained Earnings(1.6 B)9.33 B
Working Capital233.28 M1.48 B
Current Asset115.89 M9.34 B
Note: Disposition of 600000 shares by Scarlett John A of Geron at 2.54 subject to Rule 16b-3 [view details]

Geron Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Geron . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Geron Buy or Sell Advice

When is the right time to buy or sell Geron? Buying financial instruments such as Geron Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Geron in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Natural Foods Thematic Idea Now

Natural Foods
Natural Foods Theme
Companies producing natural foods including dairy products and different types of meets. The Natural Foods theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Natural Foods Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock:
Check out Geron Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.32)
Revenue Per Share
0.047
Quarterly Revenue Growth
171.384
Return On Assets
(0.30)
Return On Equity
(0.69)
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.